Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Paolini John F., Directeur Médical. Director active across 2 companies, notably Kiniksa Pharmaceuticals, Ltd.. Aggregated, 26 disclosures have been recorded. History available since 7 November 2022. The latest transaction was filed on 7 April 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Paolini John F.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5,676 sharesClass A Common ShareSEC:0001415889-22-003283:0
25 of 26 declarations
About Paolini John F.
John F. Paolini is the Chief Medical Officer at Kiniksa Pharmaceuticals, Ltd. He is responsible for medical leadership and overseeing research initiatives. Paolini leverages his expertise to ensure that the company's practices meet the highest medical standards.